AI/Machine Learning for Early Drug Discovery – Part 2 Icon

Cambridge Healthtech Institute’s 6th Annual

AI/Machine Learning for Early Drug Discovery – Part 2

Generative AI & Predictive Algorithms for Small Molecule & Peptide Therapeutics

APRIL 3 - 4, 2024


Artificial Intelligence (AI)/Machine Learning (ML) for Early Drug Discovery is a two-part conference that brings together a diverse group of experts from chemistry, target discovery, pharmacology and bioinformatics, to talk about the increasing use of computational tools, models, algorithms and data analytics for drug development. The talks will highlight the pros and cons of AI/ML-driven decision-making using relevant case studies from small molecule and peptide drug development. The second part of this conference will focus on emerging computational tools and models to identify new drug targets, predict PK/PD and safety issues in drug candidates, and to drive niche applications in drug discovery.

Please click here to return to the agenda for AI/Machine Learning – Part 1

For more details on the conference, please contact:

Tanuja Koppal, PhD

Senior Conference Director

Cambridge Healthtech Institute



For sponsorship information, please contact:

Kristin Skahan

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-5431